...
首页> 外文期刊>Journal of biomedical materials research, Part A >Collagen-coated polylactide microcarriers/chitosan hydrogel composite: injectable scaffold for cartilage regeneration.
【24h】

Collagen-coated polylactide microcarriers/chitosan hydrogel composite: injectable scaffold for cartilage regeneration.

机译:胶原蛋白包被的聚乳酸微载体/壳聚糖水凝胶复合材料:用于软骨再生的可注射支架。

获取原文
获取原文并翻译 | 示例
           

摘要

A novel structure of injectable scaffold is designed and fabricated by combining collagen-coated polylactide (PLA) microcarriers and crosslinkable chitosan hydrogel. The collagen-coated PLA microcarriers were firstly mixed with the hydrogel precursor, a thickening agent of konjac glucomannan (KGM), and redox initiators of ammonium persulfate and tetramethylethylenediamine (TMEDA). The mixture was then injected into a mold and incubated at 37 degrees C to obtain the composite scaffold. The hydrogel can deliver the collagen-coated PLA microcarriers to the desired site and, after gelation, will prevent them from uncontrolled movement. On the other hand, the collagen-coated PLA microcarriers can substantially enhance the mechanical properties of the composite system. It was found that the microcarriers suspended stably in 0.6% KGM/1% chitosan derivative (CML) solution at 37 degrees C at least for 15 min. The dynamic elastic modulus (G') of the composite scaffold increased along with the increase of the microcarrier content. G' of the composite scaffold with 10% microcarriers was measured as 0.87-2.15 MPa at a frequency range of 0.1-100 rad/s, which was 120-90 times higher than that of its hydrogel system alone (12.1-24.4 kPa). In vitro culture of chondrocytes/composite scaffold showed that the cell metabolic activity increased rapidly before day 9, then leveled off. Cells in the hydrogel could attach and grow on the surface of the collagen-coated PLA microcarriers to form confluent cell layers after days 9-12. These features make the composite scaffold to be injectable and applicable in either tissue engineering, or regenerative medicine, and in particular, in orthopaedics.
机译:通过结合胶原蛋白涂层的聚乳酸(PLA)微载体和可交联的壳聚糖水凝胶设计和制造了一种新型的可注射支架结构。首先将涂有胶原蛋白的PLA微载体与水凝胶前体,魔芋葡甘露聚糖(KGM)的增稠剂以及过硫酸铵和四甲基乙二胺(TMEDA)的氧化还原引发剂混合。然后将混合物注入模具中并在37℃下孵育以获得复合支架。水凝胶可将胶原蛋白包被的PLA微载体递送至所需部位,并且在胶凝后,将防止它们不受控制地运动。另一方面,胶原包被的PLA微载体可以显着增强复合系统的机械性能。发现微载体在37℃至少稳定地悬浮在0.6%KGM / 1%壳聚糖衍生物(CML)溶液中至少15分钟。复合支架的动态弹性模量(G')随着微载体含量的增加而增加。在0.1-100 rad / s的频率范围内,含10%微载体的复合支架的G'测量为0.87-2.15 MPa,比其单独的水凝胶体系(12.1-24.4 kPa)高120-90倍。软骨细胞/复合支架的体外培养显示,细胞代谢活性在第9天之前迅速增加,然后趋于平稳。 9-12天后,水凝胶中的细胞可以附着并在胶原蛋白包被的PLA微载体表面上生长,从而形成融合的细胞层。这些特征使得该复合支架可注射并适用于组织工程学或再生医学,尤其是骨科。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号